- Home
- CAC vs ORIC Comparison
CAC vs ORIC Comparison
Compare CAC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAC | ORIC |
|---|---|---|
| Founded | 1875 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.5M | 783.0M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CAC | ORIC |
|---|---|---|
| Price | $44.52 | $8.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $47.33 | $19.50 |
| AVG Volume (30 Days) | 79.8K | ★ 1.4M |
| Earning Date | 01-27-2026 | 11-13-2025 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | ★ 9.13 | N/A |
| EPS | ★ 3.49 | N/A |
| Revenue | ★ $215,172,000.00 | N/A |
| Revenue This Year | $44.50 | N/A |
| Revenue Next Year | $7.82 | N/A |
| P/E Ratio | $12.76 | ★ N/A |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $34.53 | $3.90 |
| 52 Week High | $46.80 | $14.93 |
Technical Indicators
Market Signals| Indicator | CAC | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 60.29 | 27.80 |
| Support Level | $43.60 | $7.98 |
| Resistance Level | $46.80 | $8.62 |
| Average True Range (ATR) | 0.96 | 0.59 |
| MACD | -0.17 | -0.07 |
| Stochastic Oscillator | 48.62 | 6.52 |
Price Performance
Historical ComparisonAbout CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.